Patricia A. Martin
Director · 3 filings · Latest: Apr 10, 2026
AN2 Therapeutics, Inc.
CYPHERPUNK TECHNOLOGIES INC.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|
ANTX | Patricia A. Martin | Director | Apr 10, 2026 | Grant/Award | $0.00 | 1,192 | — | 18,097 | |
CYPH | Patricia A. Martin | Director | Mar 13, 2026 | Option Exercise | — | 168,750 | — | 168,750 | |